Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for ...

Breast cancer detection in its early stages significantly improves survival rates, according to medical experts. While ...

Having counseled thousands of patients through their breast cancer diagnosis, I was fully aware of how nondiscriminatory this ...

Sanofi SNY announced that the phase III IRAKLIA study, which evaluated a fixed-dose subcutaneous (SC) formulation of its ...

Global pharmaceutical companies are rapidly changing cancer treatment injections. The advent of subcutaneous (SC) formulations, which dramatically reduce administration time compared to ...

for subcutaneous injection across all currently approved solid tumor indications for intravenous (IV) nivolumab (Opdivo), including renal cell carcinoma, melanoma, non–small cell lung cancer, and ...

The FDA has approved the subcutaneous formulation of nivolumab (Opdivo). This approval makes it the first and only subcutaneously administered PD-1 inhibitor. Subcutaneous nivolumab is approved in all ...

In some cases, certain types of breast calcifications may suggest early breast cancer. There are two types of breast calcifications: Macrocalcifications look like large white dots on a mammogram ...

Oncological Surgery Clinic, The Holycross Cancer Centre, Kielce, Poland Scientific Research, Epidemiology and R&D Centre, The Holycross Cancer Centre, Kielce, Poland Jan Kochanowski University ...

After her mom was diagnosed with breast cancer, Dance Moms alum Paige Hyland ... have a breast ultrasound done because she discovered a lump during a self-exam. “I’m a little bit nervous ...